Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)

The Robocop trial is an international multi-centre, single blinded, randomized controlled superiority trial conducted in centres experienced in robotic-assisted liver surgery. Eligible patients for radical cholecystectomy will be randomized in a 1:1 ratio to undergo robotic-assisted or open resection within an enhanced recovery setting. The primary endpoint is time to functional recovery. Secondary endpoints include length of hospital stay, resection margin, number of retrieved lymph nodes, postoperative complications, quality of life, abdominal wall complaints and direct and indirect costs.

NCT Number	NCT06246448
Lead Sponsor	Karolinska University Hospital Collaborators: University Hospital, Linkoeping, Sahlgrenska University Hospital, Rigshospitalet, Denmark
Conditions	Gall Bladder Cancer
Enrollment	94 participants
Start Date	2024-01-23
Primary Completion	2026-10 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-09-05